Novartis links with IBM Watson Health on breast cancer

06:41 EDT 6 Jun 2017 | PharmaTimes

Novartis and IBM Watson are teaming up in a “ground-breaking collaboration” that aims to marry machine learning with real-world data to improve outcomes in advanced breast cancer.

Original Article: Novartis links with IBM Watson Health on breast cancer


More From BioPortfolio on "Novartis links with IBM Watson Health on breast cancer"

Quick Search

Relevant Topics

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...